Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies (scientific article published on March 2009)

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

Q22241929

TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study

Q24657292

Smoking-gender interaction and risk for rheumatoid arthritis

Q24804476

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

Q27860872

Methods to evaluate risks for composite end points and their individual components

Q28168513

Cardiovascular risk factors in women with and without rheumatoid arthritis

Q28171426

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial

Q28182721

Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial

Q28182767

C-reactive protein in the prediction of rheumatoid arthritis in women

Q28212249

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

Q28218670

A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis

Q28267921

The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis

Q28306666

Role of cytokines in rheumatoid arthritis

Q29620713

Oral contraceptives and rheumatoid arthritis: new data from the Royal College of General Practitioners' oral contraception study

Q33563006

Lifestyle and the risk of rheumatoid arthritis: cigarette smoking and alcohol consumption

Q33563216

A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis

Q33982255

Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen collection

Q77221698

Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis

Q78025442

Can we accurately predict the development of rheumatoid arthritis in the preclinical phase?

Q79162973

Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus

Q79171865

Circulating levels of tumor necrosis factor receptors are highly predictive of mortality in patients with rheumatoid arthritis

Q80123752

Estimation of multiple relative risk functions in matched case-control studies

Q34283325

Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis

Q34327330

Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides

Q34569421

Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases

Q35201241

Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis

Q35636947

Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis.

Q35638187

Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study

Q35941063

Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines

Q35953412

Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women

Q36496352

STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus

Q37070948

Two independent alleles at 6q23 associated with risk of rheumatoid arthritis

Q37120830

Rheumatoid factors

Q39673146

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors

Q40532147

Diagnosis and treatment of pre-insulin dependent diabetes

Q40866289

Oral contraceptives and rheumatoid arthritis: results from a primary care-based incident case-control study

Q41523520

A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination

Q42676934

Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis

Q43937864

Effects of insulin in relatives of patients with type 1 diabetes mellitus

Q44010590

Current tobacco smoking, formal education, and the risk of rheumatoid arthritis.

Q44183395

Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women

Q44488009

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

Q44616885

Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer

Q44846719

Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.

Q45132239

Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis

Q47995699

The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality.

Q50592760

The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985.

Q50639396

Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England.

Q50925165

A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.

Q51475491

Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis.

Q55038939

Smoking and risk of rheumatoid arthritis.

Q55066113

Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials

Q59192158

Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases

Q61628153

Rheumatoid arthritis in women: Incidence rates in group health cooperative, seattle, washington, 1987-1989

Q67771292

Oral contraceptives, cigarette smoking and other factors in relation to arthritis

Q69209042

A connective tissue disease screening questionnaire for population studies

Q70785085

A screening strategy for population studies in systemic lupus erythematosus. Series design

Q72074130

Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?

Q73249220

Serum C-reactive protein does not predict rheumatoid arthritis

Q73797327

Do elevated levels of serum C-reactive protein predict rheumatoid arthritis in men: correlations with pre-RA status and baseline positive rheumatoid factors

Q74828262

Autoantibodies as predictors of disease

Q77198401

P433

issue

P921

main subject

inflammation

rheumatoid arthritis

biomarker

page(s)

641-652

P577

publication date

2009-03-01

P1433

published in

Arthritis & Rheumatology

Q4797636

P1476

title

Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies

P478

volume

Reverse relations

cites work (P2860)

Q36094049	A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative disease.
Q36535457	A Prospective Study Investigating Prediagnostic Leukocyte Telomere Length and Risk of Developing Rheumatoid Arthritis in Women
Q34372743	Alcohol consumption and markers of inflammation in women with preclinical rheumatoid arthritis
Q34153048	Alterations in the self-renewal and differentiation ability of bone marrow mesenchymal stem cells in a mouse model of rheumatoid arthritis
Q37636808	Anti-citrullinated peptide autoantibodies, human leukocyte antigen shared epitope and risk of future rheumatoid arthritis: a nested case-control study
Q40405276	Are obesity, ACPAs and periodontitis conditions that influence the risk of developing rheumatoid arthritis in first-degree relatives?
Q36761375	Assessing incremental value of biomarkers with multi-phase nested case-control studies
Q37238764	Assessment of biomarkers for risk prediction with nested case-control studies
Q36923866	Association Between Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease
Q37087883	Association of environmental and genetic factors and gene-environment interactions with risk of developing rheumatoid arthritis
Q50879987	Autoantibodies in prediction of the development of rheumatoid arthritis among healthy relatives of patients with the disease.
Q37492376	Autoimmunity to citrullinated proteins and the initiation of rheumatoid arthritis
Q34392481	Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study
Q33646020	C-reactive protein, interleukin-6, soluble tumor necrosis factor α receptor 2 and incident clinical depression
Q37589108	Can rheumatoid arthritis be prevented?
Q37801737	Cell and cytokine imbalances in rheumatoid synovitis
Q37621942	Comparison of the 1987 American College of Rheumatology and the 2010 American College of Rheumatology/European League against Rheumatism criteria for classification of rheumatoid arthritis in the Nurses' Health Study cohorts
Q34103237	Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk
Q22306446	Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity
Q38220638	Defining populations at risk of rheumatoid arthritis: the first steps to prevention
Q99554946	Depression and subsequent risk for incident rheumatoid arthritis among women
Q37454068	Developments in the scientific understanding of rheumatoid arthritis
Q47314784	Disclosure of personalized rheumatoid arthritis risk using genetics, biomarkers, and lifestyle factors to motivate health behavior improvements:A randomized controlled trial
Q45973867	Does TNF-alpha blockade play any role in cardiovascular risk among rheumatoid arthritis (RA) patients?
Q51018383	Elevated BMI and antibodies to citrullinated proteins interact to increase rheumatoid arthritis risk and shorten time to diagnosis: A nested case-control study of women in the Nurses' Health Studies.
Q41633169	Elevated IgA Plasmablast Levels in Subjects at Risk of Developing Rheumatoid Arthritis.
Q36540710	Endometriosis and the risks of systemic lupus erythematosus and rheumatoid arthritis in the Nurses' Health Study II.
Q34751981	Exogenous IFN-beta regulates the RANKL-c-Fos-IFN-beta signaling pathway in the collagen antibody-induced arthritis model
Q34166023	Familial clustering of the serum cytokine profile in the relatives of rheumatoid arthritis patients.
Q38337833	Gene expression profiling in peripheral blood cells of patients with rheumatoid arthritis in response to anti-TNF-alpha treatments
Q31031177	Genetic risk score predicting risk of rheumatoid arthritis phenotypes and age of symptom onset
Q42871652	Getting them even earlier: Identifying individuals before clinical presentation with rheumatoid arthritis
Q92106905	IL-6 Mediated Transcriptional Programming of Naïve CD4+ T Cells in Early Rheumatoid Arthritis Drives Dysregulated Effector Function
Q35059538	Immunosenescence and rheumatoid arthritis: does telomere shortening predict impending disease?
Q36017113	Inclusion of gene-gene and gene-environment interactions unlikely to dramatically improve risk prediction for complex diseases
Q38599659	Increased levels of inflammatory proteins typify the earliest phase of systemic sclerosis
Q36417817	Inflammation and early-life abuse in women
Q34604615	Insights from populations at risk for the future development of classified rheumatoid arthritis
Q64269703	Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis
Q42423867	Learning about the natural history of rheumatoid arthritis development through prospective study of subjects at high risk of rheumatoid arthritis-related autoimmunity
Q38991161	Long-term dietary quality and risk of developing rheumatoid arthritis in women
Q89808044	Measuring ACPA in the general population or primary care: is it useful?
Q35209064	Mediterranean diet and incidence of rheumatoid arthritis in women
Q35983908	Monocyte chemotactic protein-1 elevation prior to the onset of rheumatoid arthritis among women.
Q27003201	Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE
Q58572457	Pharmacologic Effect of Miao Medicine Maxim. on Collagen-Induced Arthritis in Rats
Q26863441	Preclinical rheumatoid arthritis (autoantibodies): an updated review
Q33890221	Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigation
Q38893197	Preventive Treatments for Rheumatoid Arthritis: Issues Regarding Patient Preferences
Q34198784	Progeroid syndromes: models for stem cell aging?
Q37358099	Recent advances in neutralizing the IL-6 pathway in arthritis.
Q37478738	Resampling Procedures for Making Inference under Nested Case-control Studies
Q57165511	Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction
Q37583658	Screening tests for inflammatory activity: applications in rheumatology
Q58051983	Serum levels of anticyclic citrullinated peptide antibodies, interleukin-6, tumor necrosis factor-α, and C-reactive protein are associated with increased carotid intima-media thickness: a cross-sectional analysis of a cohort of rheumatoid arthritis
Q36366153	Strategies to predict rheumatoid arthritis development in at-risk populations
Q33765720	Subclinical inflammation on MRI of hand and foot of anticitrullinated peptide antibody-negative arthralgia patients at risk for rheumatoid arthritis
Q34056227	Sugar-sweetened soda consumption and risk of developing rheumatoid arthritis in women
Q44508845	The changing face of rheumatoid arthritis: sustained remission for all?
Q34307377	The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner
Q44071398	The preclinical phase of rheumatoid arthritis: what is acknowledged and what needs to be assessed?
Q38968009	The role of female hormonal factors in the development of rheumatoid arthritis
Q37705418	Unraveling the interactions between environmental factors and genetic polymorphisms in non-Hodgkin lymphoma risk
Q43749611	Visfatin and adiponectin as novel markers for evaluation of metabolic disturbance in recently diagnosed rheumatoid arthritis patients
Q30491980	Wellbeing and Arthritis Incidence: The Role of Inflammatory Mechanisms. Findings from the English Longitudinal Study of Ageing

P356	DOI	10.1002/ART.24350
P8608	Fatcat ID	release_uyt7kj47qfej3k32dqocbbwh5i
P932	PMC publication ID	2715148
P698	PubMed publication ID	19248103
P5875	ResearchGate publication ID	24045309